Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £29.80m
SBTX Live PriceLast checked at - London Stock Exchange

Intraday Skinbiotherap. Share Chart

Date   Source Headline
27th Feb 20247:00 amRNSPositive Interim AxisBiotix Acne study results
20th Feb 20247:00 amRNSDermatonics to launch Once Heel Balm in AMEA
9th Feb 20247:00 amRNSConversion Notice and Total Voting Rights
6th Feb 20247:31 amRNSDermatonics Full Year trading update
26th Jan 20247:00 amRNSCompletion of Acquisition of Dermatonics
25th Jan 20247:00 amRNSAcquisition of Dermatonics
25th Jan 20247:00 amRNS£5.0m Convertible Bond Facility & First Drawdown
29th Dec 202310:49 amRNSResult of AGM
29th Dec 20238:13 amRNSUpdate on transaction timelines to early 2024
6th Dec 20237:00 amRNSNotice of AGM and posting of Annual Report
30th Nov 20235:25 pmRNSFinal Results
30th Nov 20237:00 amRNSAxisBiotix-Psâ„¢ to launch on Amazon UK
24th Nov 20237:00 amRNSHolding(s) in Company
23rd Nov 20233:37 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
21st Nov 20237:00 amRNSResult of Retail Offer
17th Nov 20237:00 amRNSResult of Placing
16th Nov 20234:35 pmRNSRetail Offer
16th Nov 20234:33 pmRNSPlacing and Retail Offer
25th Oct 20237:25 amRNSAcne study, Trading and Auditor updates
19th Oct 20237:00 amRNSExtension of Croda contract for SkinBiotixâ„¢
15th Sep 20239:00 amRNShealth authority approval for AxisBiotix in France
5th Sep 20237:00 amRNSUpdate on acne programme
31st Jul 202312:51 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSRegulatory Approval
14th Jun 20234:46 pmRNSBusiness progress update
10th May 20237:00 amRNSSkinBiotix and AxisBiotix Update
14th Apr 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20231:45 pmRNSReplacement Half-year Report
28th Mar 20237:00 amRNSHalf-year Report
27th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20235:18 pmRNSDirector/PDMR Shareholding
9th Mar 20235:18 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSAxisBiotix-Ps™ approved for launch in Europe
20th Feb 202311:17 amRNSHolding(s) in Company
31st Jan 202311:15 amRNSResult of General Meeting
30th Jan 20234:28 pmRNSHolding(s) in Company
30th Jan 20239:00 amRNSHolding(s) in Company
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
6th Jan 20237:44 amRNSNotice of General Meeting - Replacement
6th Jan 20237:00 amRNSNotice of General Meeting
4th Jan 20231:33 pmRNSResult of General Meeting
30th Dec 202211:33 amRNSResults of AGM
23rd Dec 20227:00 amRNSReport and Accounts, and Provision Update
21st Dec 20227:00 amRNSResult of Retail Offer
19th Dec 202211:15 amEQSSkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'
16th Dec 20227:00 amRNSResult of Placing
15th Dec 20224:32 pmRNSREX Retail Offer
15th Dec 20224:31 pmRNSPlacing and REX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.